Mmrglobal Inc (MMRF) 0.0100 $MMRF
MMRGlobal & Defendants in Patent Suits Amenable to Settlement Talks in Federal Appellate Mediation Program
Marketwired - Mon Feb 09, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR"
, today announced that in their respective Docketing Statements filed with the Court of Appeals for the Federal Circuit, MMR, WebMD and Quest Diagnostics confirmed that they would participate in an Appellate Mediation Program at the United States Court of Appeals for the Federal Circuit. On February 5, 2015, WebMD and Quest Diagnostics filed their respective Docketing Statements that they were amenable to mediation by the Appellate Mediation Program. In the filings, WebMD and Quest Diagnostics acknowledged that past settlement negotiations with MMR had occurred following the orders which are the subject of the appeal, and both agreed that mediation may assist in the efficient resolution of the matters. Although assignment to mediation is at the discretion of the Circuit Executive, once selected, participation in the mediation program is mandatory. The assignment to mediation is not confidential, however, the substance of any settlement talks or mediation is confidential and may not be disclosed by any participant.
MMRGlobal Biotech Assets in Play as Company Is Awarded Second U.S. Cancer Fighting Patent
Marketwired - Mon Feb 02, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" , a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals, today announced that U.S. Patent No. 8,945,550 will issue on February 3, 2015, providing the second U.S. patent, in addition to patents in Australia, Mexico and South Korea, for the Company's anti-CD20 monoclonal antibody technology. MMR also announced that it is in talks to sell more than 2,000 patient samples and data from its FavId(TM) vaccine trials to treat lymphoma patients with two major biotech companies that could use the samples for research and development or in connection with drug approval. This second MMR U.S. biotech patent relates to methods of treatment using the anti-CD20 monoclonal antibodies and will be issued under the title, "Antibodies and Methods For Making and Using Them."
MMRGlobal Announces New Patent Agreement & Increased Distribution Channel
Marketwired - Wed Jan 28, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" today announced that the Company will report retailer-driven revenue in the fourth quarter 2014 from Patent Agreements, in addition to the previously disclosed licensing agreements with the nation's largest pharmacy retailer, which substantially increases MMR's previously disclosed retail distribution channel that includes access to more than 15,000 U.S. retail locations, 2,000 international locations, and 50 million monthly online visitors. MMR has already received initial revenues from the signing of the agreements related to the increased distribution network during the period ended December 31, 2014. MMRGlobal also announced 2014 was the highest revenue year in the Company's history and that MMR continues to actively pursue strategic opportunities with partners who have the financial resources to make large investments in MMR's technology products, services and Intellectual Property. As part of that, the Company is in the process of completing another Patent Agreement and strategic partnership with a major healthcare provider. Additional details will be announced when the terms of that agreement are finalized.
MMRGlobal Proceeds With $30 Million Patent Licensing Case and Files Three New Federal Appeals
Marketwired - Tue Jan 20, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR" , today announced that following the California Court of Appeal's finding that the trial court erred in granting Surgery Center Management, LLC's ("SCM" motion for summary adjudication, the trial court vacated its order, thereby paving the way for MMR to have the opportunity to proceed with its $30,000,000 patent licensing case against SCM. This ruling represents the second time in this lawsuit that the Court of Appeal interceded with rulings favorable to MMR, highlighting the critical role of appellate courts in ensuring the correct application of law and that justice is ultimately accomplished.
WBMD: 39.12 (+0.42), MDRX: 11.80 (+0.04)
Shareholder Update & Roadmap for MyMedicalRecords Patent Portfolio
Marketwired - Wed Dec 24, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR" , today announced that the U.S. District Court for the Central District of California issued an order in response to a motion for judgment on the pleadings agreeing that claims 8-12 of U.S. Patent No. 8,301,466 ("the '466 patent" were directed towards an abstract idea and therefore not directed towards patent eligible subject matter. The '466 patent contains 15 claims, 10 of which are not affected by the Order. The ruling also does not affect other portions of MMR's health information technology patent portfolio which, dating back to filings in 2005, currently includes 13 U.S. patents (with over 300 issued claims), 18 additional pending U.S. patent applications (with over 300 claims), nine foreign patents, including two in Australia, two in Mexico, with others in New Zealand, Singapore, Japan, South Korea, and Canada, and 25 other pending patent applications in foreign countries. The Court's Order does not affect these other patents.
MMRGlobal Cyber Liability Insurance Program Protects Patients, Subscribers & Physicians From Losses Against Hacking Into Protected Health Information
Marketwired - Thu Dec 18, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" today called attention to the Company's Million Dollar Cyber Liability Insurance program whereby the protected health information of patients, subscribers, employers and healthcare professionals stored in MMR's MyMedicalRecords Personal Health Record ("PHR" systems is protected against unauthorized intrusion under the program. The Cyber Liability Insurance program also includes protection from actual loss or damage caused in defending violations of expanded HIPAA regulations under the HITECH Act, which provides for significant financial penalties. The MMR program is backed by an A-rated insurance company as reviewed by A.M. Best who underwrites the underlying Cyber Liability coverage extending to MyMedicalRecords' users.
MMRGlobal Adds Health Information Technology Patents in Korea, Mexico & New Zealand
Marketwired - Tue Dec 16, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly-owned subsidiary, MyMedicalRecords, Inc. (collectively "MMR" or the "Company" , today announced four new health information technology patents which are to issue including two patents in South Korea and additional patents in Mexico and New Zealand. MMR is a practicing entity and a leading provider of Personal Health Records ("PHRs" through its patented MyMedicalRecords product and service offerings. Robert H. Lorsch, Chairman and CEO of MMRGlobal, said, "The Company continues to add numerous patents both domestically and internationally in tandem with the revolution in health information technology happening all over the world. MMR is well positioned for the future of healthcare today as millions of consumers become engaged in better managing their care by tracking their personal health information."
MMRGlobal Subsidiary Receives Favorable Appellate Court Order Pertaining to MyMedicalRecords, Inc. $30 Million License Agreement
Marketwired - Tue Dec 09, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR" , today announced that on Friday, December 5, 2014, the California Court of Appeal issued an Alternative Writ of Mandate, finding the trial court "erred in granting [Surgery Center Management, LLC's ("SCM" ] motion for summary adjudication". The Company believes that the Court of Appeal's Alternative Order shall soon clear the way for MMR to continue pursuing its claim for as much as $30 million against SCM. It would be the second time the Court of Appeal ruled in favor of MMR in this matter. The full case would then be remanded back to the Los Angeles County Superior Court, where MMR will continue to pursue its claim for breach of contract.
MMRGlobal Projects Record-Breaking Revenue Driven by Licensing, Subscriptions During Open Enrollment & Healthcare.gov
Marketwired - Wed Nov 19, 3:28PM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company" , a leading provider of Personal Health Records ("PHRs" through its patented MyMedicalRecords product and service offerings, is calling attention to the value of having a Personal Health Record as employees enter open enrollment season and consumers sign up at Healthcare.gov and other statewide exchanges now through February 15th. With hundreds of millions of dollars being spent in advertising by insurers and the government to drive consumers to sign up for health insurance, the Company is joining the media foray with the launch of its own advertising and sales promotion campaign entitled "Your Family's Health Connected" on nationally syndicated television and major national retailer websites. The campaign calls consumers to "Be Prepared for Open Enrollment & Healthcare.gov with a Personal Health Record Kit from MyMedicalRecords."
MMRGlobal reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 10:00AM CST
MMRGlobal Reports Record 3rd Quarter Revenue Increase of More Than 1,500%
Marketwired - Thu Nov 13, 7:22AM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company" , a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and electronic document management systems for consumers and healthcare professionals, today filed its quarterly financial report on Form 10-Q for the period ended September 30, 2014 with the United States Securities and Exchange Commission. The Company announced a 1,584% increase in revenues for the third quarter of 2014, as compared to the third quarter of 2013. During the quarter, the Company recorded revenues of $1,896,271, and gross profit of $1,807,311. The Company also reported cash on hand of $1,491,510 at the end of the quarter. The Company's quarterly revenues were driven by licensing and other sources and represent the highest quarter in MMR's history. The Company also announced that in 2014 it will report its biggest year since its inception. For the nine months ended September 30, 2014, the Company reported revenues of $2,437,095 as compared to $535,146 for the same period last year, an increase of 355.4%. Net cash provided by operating activities for the nine months ended September 30, 2014 was $226,382, compared to net cash used of $2,174,399 in the similar period in 2013.
MMRGlobal Cracks the Code on Electronic Medical Records Interoperability
Marketwired - Mon Oct 27, 9:35AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) and its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR" , was profiled in Breitbart News today (http://goo.gl/8TFxFr). MMR is a health information technology company whose primary business is Electronic Medical Records with an emphasis on the Personal Health Record ("PHR" market. MMR sells its proprietary interoperable MyMedicalRecords Personal Health Record Kit available directly online and at retailers everywhere. MyMedicalRecords enables patients and their family the ability to securely access, manage and control their protected health information. An October 21st story entitled "Ebola Patient's Electronic Medical Records 'Glitch' Casts Light on $25 Billion Obama Stimulus Boondoggle" highlighted the MyMedicalRecords PHR. Since its release, and as of yesterday, the story continues to be the highest ranking "Electronic Medical Records" story on Google Search -- above "Electronic Medical Records" in The New York Times. The Company attributes this to consumer interest in securely managing and controlling access to their personal health information from all of their medical providers in one convenient place. The MyMedicalRecords PHR also includes built-in automated reminders which can be programmed to take your medication, take your blood pressure, check your insulin, and in the wake of the Ebola outbreak, take your temperature. The Personal Health Record also includes an emergency access portal to share patient-controlled medical records with physicians and first responders in the event of an emergency or natural disaster as featured in a nationally syndicated television commercial that can be seen at https://www.youtube.com/watch?v=MF5P2tOoSE4&a...e=youtu.be.
MyMedicalRecords Launches Television Advertising for Interoperable Personal Health Record on Sale at National Retailers
Marketwired - Mon Oct 13, 7:16AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" today announced that the Company is launching a national television advertising campaign for its MyMedicalRecords Personal Health Record ("PHR" through Associated Television International (www.ati.com). Consumers are becoming more aware of the importance of having a Personal Health Record so that in the event of a medical emergency or disaster, copies of their actual medical records, important documents and travel history are securely available from any Internet-connected device. Two nationally syndicated television commercials, including retailer tags, can also be seen at http://youtu.be/0vlP-V4sjAg and http://youtu.be/MF5P2tOoSE4. The commercials focus on the value of being prepared for any medical emergency and the benefits of having a PHR as part of a family's disaster preparedness plan.
MMRGlobal to Report Third Quarter Revenue Exceeding Biggest Year in Company History
Marketwire - Mon Oct 06, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company" today announced that it will report third quarter revenues from all sources in excess of total revenues from its biggest year. The Health Information Technology and Biotechnology Company will report substantially more revenue than the $1.420 million reported from the entire calendar year of 2011, previously the biggest year in the Company's history and which the Company has received in cash. Additional information will be contained in the Company's quarterly report on Form 10-Q for the period ended September 30, 2014. According to MMRGlobal CEO Robert H. Lorsch, "In a letter to shareholders earlier this year, the Company projected that 2014 would be 'our year' and at this time it appears that it is." The Company licenses and sells worldwide Health Information Technology and Biotech intellectual property rights, including international patents, vaccine and patient samples and anti-CD20 monoclonal antibodies.
MMRGlobal Announces Emergency Access Patent in Mexico
Marketwire - Thu Sep 25, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR" , today announced that the Mexican Institute of Industrial Property (IMPI) has issued an official Notice of Allowance for Mexican Patent Application No. MX/a/2012/001633. The allowed patent application is directed toward computer systems for managing Personal Health Records and communicating with healthcare providers. Of particular significance is an emergency access feature that allows emergency responders or healthcare providers to have access to important health information in a user's Personal Health Record account in the event of an emergency. MMR has additional patent applications pending relating to the emergency access feature in the U.S. and elsewhere throughout the world.
MMRGlobal Announces Final Settlement Conference and Jury Trial Dates in MyMedicalRecords Patent Litigation
Marketwire - Mon Sep 22, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR" , announced today that a Post-Markman Scheduling Order was entered by the United States District Court, Central District of California on September 19, 2014 in plaintiff MyMedicalRecords patent infringement cases against defendants Quest Diagnostics, Inc., Jardogs, LLC, Allscripts Healthcare Solutions, Inc., and WebMD Health Corp. & WebMD Health Services Group, Inc. MyMedicalRecords is pleased that the Court denied Defendants' request to stay discovery and instead opened discovery through 2/18/2015, also setting a last date to conduct settlement conferences of 3/18/2015 and a Jury Trial starting 5/19/2015. A complete copy of the comprehensive scheduling order leading to trial can be found on PACER at http://www.pacer.gov/.
WBMD: 39.12 (+0.42), DGX: 71.68 (+0.03), MDRX: 11.80 (+0.04)
MMRGlobal Receives Significant Intellectual Property Milestone Payment
Marketwire - Wed Sep 17, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company" today announced that it has received another significant milestone payment pursuant to an existing Non-Exclusive License Agreement (the "Agreement" pertaining to the Company's biotech assets. Additional information regarding this milestone payment will be contained in the Company's quarterly report on Form 10-Q for the quarter ending September 30, 2014. The non-exclusive Agreement licenses the use of the Company's clinical and scientific data relating to targeted immunotherapies for cancer and other disease treatments to stimulate a patient's immune response and certain other confidential information.
MMRGlobal Announces Claim Construction Order Adopts Six of Eight Plaintiff Proposed Claim Terms
Marketwire - Mon Sep 08, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR" , today announced that on September 3, 2014, a Claim Construction Order was issued in the consolidated patent infringement suits between plaintiff MyMedicalRecords, Inc., and defendant(s) Quest Diagnostics, Inc., Empty Jar, LLC f/k/a Jardogs, LLC, Allscripts Healthcare Solutions, Inc., and WebMD Health Corp. and WebMD Health Services Group. MMR now looks forward to proceeding with discovery and preparing for trial.
WBMD: 39.12 (+0.42), DGX: 71.68 (+0.03), MDRX: 11.80 (+0.04)
MMRGlobal Reports Q2 & Year-to-Date Results
Marketwire - Fri Aug 15, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company" reported in its 10-Q filed August 14, 2014 that for the six months ended June 30, 2014, revenues were 26% greater over 2013 despite the fact that second quarter revenues were lower for the same period last year. The Company was also focused on its ongoing patent litigation matters during the second quarter. In particular, MyMedicalRecords, Inc., a wholly owned subsidiary of MMRGlobal, has been preparing for an upcoming Markman hearing pertaining to two of its patents, which is scheduled for August 19, 2014 (MyMedicalRecords, Inc., United States District Court for the Central District of California, at http://www.pacer.gov/).
Fuisz-Kundu Group LLP Joins Legal Team for MyMedicalRecords, Inc. Patent Infringement Case Leading Into Markman
Marketwire - Fri Aug 08, 5:10AM CDT
The Fuisz-Kundu Group LLP announced today that it has filed an application for appearance on behalf of MyMedicalRecords, Inc., a wholly owned subsidiary of MMRGlobal, Inc. (OTCQB: MMRF), at a Markman hearing scheduled for August 19, 2014 in MyMedicalRecords, Inc.'s ongoing patent infringement lawsuits against Allscripts Healthcare Solutions, Inc., Quest Diagnostics Incorporated, Empty Jar, LLC (f/k/a/ Jardogs, LLC) and WebMD Health Corp. and WebMD Health Services Group. The consolidated patent infringement litigations pending in the Central District for the District Court in California (Case No. 2:13-cv-00631) involve MyMedicalRecords' enforcement of U.S. Patent No. 8,301,466, "Method and System for Providing Online Records," and U.S. Patent No. 8,498,883, "Method for Providing a User with a Service for Accessing and Collecting Prescriptions." The '466 and '883 patents generally relate to providing a means for consumers to request their medical records from healthcare providers, store their medical records, and provide for communications between consumers and their healthcare providers in a private and secure manner.
WBMD: 39.12 (+0.42), DGX: 71.68 (+0.03), MDRX: 11.80 (+0.04)
MMRGlobal & Defendants in Patent Suits Amenable to Settlement Talks in Federal Appellate Mediation Program
Marketwired - Mon Feb 09, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR"
, today announced that in their respective Docketing Statements filed with the Court of Appeals for the Federal Circuit, MMR, WebMD and Quest Diagnostics confirmed that they would participate in an Appellate Mediation Program at the United States Court of Appeals for the Federal Circuit. On February 5, 2015, WebMD and Quest Diagnostics filed their respective Docketing Statements that they were amenable to mediation by the Appellate Mediation Program. In the filings, WebMD and Quest Diagnostics acknowledged that past settlement negotiations with MMR had occurred following the orders which are the subject of the appeal, and both agreed that mediation may assist in the efficient resolution of the matters. Although assignment to mediation is at the discretion of the Circuit Executive, once selected, participation in the mediation program is mandatory. The assignment to mediation is not confidential, however, the substance of any settlement talks or mediation is confidential and may not be disclosed by any participant. MMRGlobal Biotech Assets in Play as Company Is Awarded Second U.S. Cancer Fighting Patent
Marketwired - Mon Feb 02, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"
, a leading provider of Personal Health Records (PHRs), MyEsafeDepositBox storage solutions and electronic document management and imaging systems for healthcare professionals, today announced that U.S. Patent No. 8,945,550 will issue on February 3, 2015, providing the second U.S. patent, in addition to patents in Australia, Mexico and South Korea, for the Company's anti-CD20 monoclonal antibody technology. MMR also announced that it is in talks to sell more than 2,000 patient samples and data from its FavId(TM) vaccine trials to treat lymphoma patients with two major biotech companies that could use the samples for research and development or in connection with drug approval. This second MMR U.S. biotech patent relates to methods of treatment using the anti-CD20 monoclonal antibodies and will be issued under the title, "Antibodies and Methods For Making and Using Them." MMRGlobal Announces New Patent Agreement & Increased Distribution Channel
Marketwired - Wed Jan 28, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"
today announced that the Company will report retailer-driven revenue in the fourth quarter 2014 from Patent Agreements, in addition to the previously disclosed licensing agreements with the nation's largest pharmacy retailer, which substantially increases MMR's previously disclosed retail distribution channel that includes access to more than 15,000 U.S. retail locations, 2,000 international locations, and 50 million monthly online visitors. MMR has already received initial revenues from the signing of the agreements related to the increased distribution network during the period ended December 31, 2014. MMRGlobal also announced 2014 was the highest revenue year in the Company's history and that MMR continues to actively pursue strategic opportunities with partners who have the financial resources to make large investments in MMR's technology products, services and Intellectual Property. As part of that, the Company is in the process of completing another Patent Agreement and strategic partnership with a major healthcare provider. Additional details will be announced when the terms of that agreement are finalized. MMRGlobal Proceeds With $30 Million Patent Licensing Case and Files Three New Federal Appeals
Marketwired - Tue Jan 20, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR"
, today announced that following the California Court of Appeal's finding that the trial court erred in granting Surgery Center Management, LLC's ("SCM" motion for summary adjudication, the trial court vacated its order, thereby paving the way for MMR to have the opportunity to proceed with its $30,000,000 patent licensing case against SCM. This ruling represents the second time in this lawsuit that the Court of Appeal interceded with rulings favorable to MMR, highlighting the critical role of appellate courts in ensuring the correct application of law and that justice is ultimately accomplished. WBMD: 39.12 (+0.42), MDRX: 11.80 (+0.04)
Shareholder Update & Roadmap for MyMedicalRecords Patent Portfolio
Marketwired - Wed Dec 24, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR"
, today announced that the U.S. District Court for the Central District of California issued an order in response to a motion for judgment on the pleadings agreeing that claims 8-12 of U.S. Patent No. 8,301,466 ("the '466 patent" were directed towards an abstract idea and therefore not directed towards patent eligible subject matter. The '466 patent contains 15 claims, 10 of which are not affected by the Order. The ruling also does not affect other portions of MMR's health information technology patent portfolio which, dating back to filings in 2005, currently includes 13 U.S. patents (with over 300 issued claims), 18 additional pending U.S. patent applications (with over 300 claims), nine foreign patents, including two in Australia, two in Mexico, with others in New Zealand, Singapore, Japan, South Korea, and Canada, and 25 other pending patent applications in foreign countries. The Court's Order does not affect these other patents. MMRGlobal Cyber Liability Insurance Program Protects Patients, Subscribers & Physicians From Losses Against Hacking Into Protected Health Information
Marketwired - Thu Dec 18, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"
today called attention to the Company's Million Dollar Cyber Liability Insurance program whereby the protected health information of patients, subscribers, employers and healthcare professionals stored in MMR's MyMedicalRecords Personal Health Record ("PHR" systems is protected against unauthorized intrusion under the program. The Cyber Liability Insurance program also includes protection from actual loss or damage caused in defending violations of expanded HIPAA regulations under the HITECH Act, which provides for significant financial penalties. The MMR program is backed by an A-rated insurance company as reviewed by A.M. Best who underwrites the underlying Cyber Liability coverage extending to MyMedicalRecords' users. MMRGlobal Adds Health Information Technology Patents in Korea, Mexico & New Zealand
Marketwired - Tue Dec 16, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly-owned subsidiary, MyMedicalRecords, Inc. (collectively "MMR" or the "Company"
, today announced four new health information technology patents which are to issue including two patents in South Korea and additional patents in Mexico and New Zealand. MMR is a practicing entity and a leading provider of Personal Health Records ("PHRs" through its patented MyMedicalRecords product and service offerings. Robert H. Lorsch, Chairman and CEO of MMRGlobal, said, "The Company continues to add numerous patents both domestically and internationally in tandem with the revolution in health information technology happening all over the world. MMR is well positioned for the future of healthcare today as millions of consumers become engaged in better managing their care by tracking their personal health information." MMRGlobal Subsidiary Receives Favorable Appellate Court Order Pertaining to MyMedicalRecords, Inc. $30 Million License Agreement
Marketwired - Tue Dec 09, 7:15AM CST
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR"
, today announced that on Friday, December 5, 2014, the California Court of Appeal issued an Alternative Writ of Mandate, finding the trial court "erred in granting [Surgery Center Management, LLC's ("SCM" ] motion for summary adjudication". The Company believes that the Court of Appeal's Alternative Order shall soon clear the way for MMR to continue pursuing its claim for as much as $30 million against SCM. It would be the second time the Court of Appeal ruled in favor of MMR in this matter. The full case would then be remanded back to the Los Angeles County Superior Court, where MMR will continue to pursue its claim for breach of contract. MMRGlobal Projects Record-Breaking Revenue Driven by Licensing, Subscriptions During Open Enrollment & Healthcare.gov
Marketwired - Wed Nov 19, 3:28PM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company"
, a leading provider of Personal Health Records ("PHRs" through its patented MyMedicalRecords product and service offerings, is calling attention to the value of having a Personal Health Record as employees enter open enrollment season and consumers sign up at Healthcare.gov and other statewide exchanges now through February 15th. With hundreds of millions of dollars being spent in advertising by insurers and the government to drive consumers to sign up for health insurance, the Company is joining the media foray with the launch of its own advertising and sales promotion campaign entitled "Your Family's Health Connected" on nationally syndicated television and major national retailer websites. The campaign calls consumers to "Be Prepared for Open Enrollment & Healthcare.gov with a Personal Health Record Kit from MyMedicalRecords." MMRGlobal reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 10:00AM CST
MMRGlobal Reports Record 3rd Quarter Revenue Increase of More Than 1,500%
Marketwired - Thu Nov 13, 7:22AM CST
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company"
, a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and electronic document management systems for consumers and healthcare professionals, today filed its quarterly financial report on Form 10-Q for the period ended September 30, 2014 with the United States Securities and Exchange Commission. The Company announced a 1,584% increase in revenues for the third quarter of 2014, as compared to the third quarter of 2013. During the quarter, the Company recorded revenues of $1,896,271, and gross profit of $1,807,311. The Company also reported cash on hand of $1,491,510 at the end of the quarter. The Company's quarterly revenues were driven by licensing and other sources and represent the highest quarter in MMR's history. The Company also announced that in 2014 it will report its biggest year since its inception. For the nine months ended September 30, 2014, the Company reported revenues of $2,437,095 as compared to $535,146 for the same period last year, an increase of 355.4%. Net cash provided by operating activities for the nine months ended September 30, 2014 was $226,382, compared to net cash used of $2,174,399 in the similar period in 2013. MMRGlobal Cracks the Code on Electronic Medical Records Interoperability
Marketwired - Mon Oct 27, 9:35AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) and its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR"
, was profiled in Breitbart News today (http://goo.gl/8TFxFr). MMR is a health information technology company whose primary business is Electronic Medical Records with an emphasis on the Personal Health Record ("PHR" market. MMR sells its proprietary interoperable MyMedicalRecords Personal Health Record Kit available directly online and at retailers everywhere. MyMedicalRecords enables patients and their family the ability to securely access, manage and control their protected health information. An October 21st story entitled "Ebola Patient's Electronic Medical Records 'Glitch' Casts Light on $25 Billion Obama Stimulus Boondoggle" highlighted the MyMedicalRecords PHR. Since its release, and as of yesterday, the story continues to be the highest ranking "Electronic Medical Records" story on Google Search -- above "Electronic Medical Records" in The New York Times. The Company attributes this to consumer interest in securely managing and controlling access to their personal health information from all of their medical providers in one convenient place. The MyMedicalRecords PHR also includes built-in automated reminders which can be programmed to take your medication, take your blood pressure, check your insulin, and in the wake of the Ebola outbreak, take your temperature. The Personal Health Record also includes an emergency access portal to share patient-controlled medical records with physicians and first responders in the event of an emergency or natural disaster as featured in a nationally syndicated television commercial that can be seen at https://www.youtube.com/watch?v=MF5P2tOoSE4&a...e=youtu.be. MyMedicalRecords Launches Television Advertising for Interoperable Personal Health Record on Sale at National Retailers
Marketwired - Mon Oct 13, 7:16AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR"
today announced that the Company is launching a national television advertising campaign for its MyMedicalRecords Personal Health Record ("PHR" through Associated Television International (www.ati.com). Consumers are becoming more aware of the importance of having a Personal Health Record so that in the event of a medical emergency or disaster, copies of their actual medical records, important documents and travel history are securely available from any Internet-connected device. Two nationally syndicated television commercials, including retailer tags, can also be seen at http://youtu.be/0vlP-V4sjAg and http://youtu.be/MF5P2tOoSE4. The commercials focus on the value of being prepared for any medical emergency and the benefits of having a PHR as part of a family's disaster preparedness plan. MMRGlobal to Report Third Quarter Revenue Exceeding Biggest Year in Company History
Marketwire - Mon Oct 06, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company"
today announced that it will report third quarter revenues from all sources in excess of total revenues from its biggest year. The Health Information Technology and Biotechnology Company will report substantially more revenue than the $1.420 million reported from the entire calendar year of 2011, previously the biggest year in the Company's history and which the Company has received in cash. Additional information will be contained in the Company's quarterly report on Form 10-Q for the period ended September 30, 2014. According to MMRGlobal CEO Robert H. Lorsch, "In a letter to shareholders earlier this year, the Company projected that 2014 would be 'our year' and at this time it appears that it is." The Company licenses and sells worldwide Health Information Technology and Biotech intellectual property rights, including international patents, vaccine and patient samples and anti-CD20 monoclonal antibodies. MMRGlobal Announces Emergency Access Patent in Mexico
Marketwire - Thu Sep 25, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"
, today announced that the Mexican Institute of Industrial Property (IMPI) has issued an official Notice of Allowance for Mexican Patent Application No. MX/a/2012/001633. The allowed patent application is directed toward computer systems for managing Personal Health Records and communicating with healthcare providers. Of particular significance is an emergency access feature that allows emergency responders or healthcare providers to have access to important health information in a user's Personal Health Record account in the event of an emergency. MMR has additional patent applications pending relating to the emergency access feature in the U.S. and elsewhere throughout the world. MMRGlobal Announces Final Settlement Conference and Jury Trial Dates in MyMedicalRecords Patent Litigation
Marketwire - Mon Sep 22, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"
, announced today that a Post-Markman Scheduling Order was entered by the United States District Court, Central District of California on September 19, 2014 in plaintiff MyMedicalRecords patent infringement cases against defendants Quest Diagnostics, Inc., Jardogs, LLC, Allscripts Healthcare Solutions, Inc., and WebMD Health Corp. & WebMD Health Services Group, Inc. MyMedicalRecords is pleased that the Court denied Defendants' request to stay discovery and instead opened discovery through 2/18/2015, also setting a last date to conduct settlement conferences of 3/18/2015 and a Jury Trial starting 5/19/2015. A complete copy of the comprehensive scheduling order leading to trial can be found on PACER at http://www.pacer.gov/. WBMD: 39.12 (+0.42), DGX: 71.68 (+0.03), MDRX: 11.80 (+0.04)
MMRGlobal Receives Significant Intellectual Property Milestone Payment
Marketwire - Wed Sep 17, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company"
today announced that it has received another significant milestone payment pursuant to an existing Non-Exclusive License Agreement (the "Agreement" pertaining to the Company's biotech assets. Additional information regarding this milestone payment will be contained in the Company's quarterly report on Form 10-Q for the quarter ending September 30, 2014. The non-exclusive Agreement licenses the use of the Company's clinical and scientific data relating to targeted immunotherapies for cancer and other disease treatments to stimulate a patient's immune response and certain other confidential information. MMRGlobal Announces Claim Construction Order Adopts Six of Eight Plaintiff Proposed Claim Terms
Marketwire - Mon Sep 08, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, "MMR"
, today announced that on September 3, 2014, a Claim Construction Order was issued in the consolidated patent infringement suits between plaintiff MyMedicalRecords, Inc., and defendant(s) Quest Diagnostics, Inc., Empty Jar, LLC f/k/a Jardogs, LLC, Allscripts Healthcare Solutions, Inc., and WebMD Health Corp. and WebMD Health Services Group. MMR now looks forward to proceeding with discovery and preparing for trial. WBMD: 39.12 (+0.42), DGX: 71.68 (+0.03), MDRX: 11.80 (+0.04)
MMRGlobal Reports Q2 & Year-to-Date Results
Marketwire - Fri Aug 15, 7:15AM CDT
MMRGlobal, Inc. (OTCQB: MMRF) ("MMR" or the "Company"
reported in its 10-Q filed August 14, 2014 that for the six months ended June 30, 2014, revenues were 26% greater over 2013 despite the fact that second quarter revenues were lower for the same period last year. The Company was also focused on its ongoing patent litigation matters during the second quarter. In particular, MyMedicalRecords, Inc., a wholly owned subsidiary of MMRGlobal, has been preparing for an upcoming Markman hearing pertaining to two of its patents, which is scheduled for August 19, 2014 (MyMedicalRecords, Inc., United States District Court for the Central District of California, at http://www.pacer.gov/). Fuisz-Kundu Group LLP Joins Legal Team for MyMedicalRecords, Inc. Patent Infringement Case Leading Into Markman
Marketwire - Fri Aug 08, 5:10AM CDT
The Fuisz-Kundu Group LLP announced today that it has filed an application for appearance on behalf of MyMedicalRecords, Inc., a wholly owned subsidiary of MMRGlobal, Inc. (OTCQB: MMRF), at a Markman hearing scheduled for August 19, 2014 in MyMedicalRecords, Inc.'s ongoing patent infringement lawsuits against Allscripts Healthcare Solutions, Inc., Quest Diagnostics Incorporated, Empty Jar, LLC (f/k/a/ Jardogs, LLC) and WebMD Health Corp. and WebMD Health Services Group. The consolidated patent infringement litigations pending in the Central District for the District Court in California (Case No. 2:13-cv-00631) involve MyMedicalRecords' enforcement of U.S. Patent No. 8,301,466, "Method and System for Providing Online Records," and U.S. Patent No. 8,498,883, "Method for Providing a User with a Service for Accessing and Collecting Prescriptions." The '466 and '883 patents generally relate to providing a means for consumers to request their medical records from healthcare providers, store their medical records, and provide for communications between consumers and their healthcare providers in a private and secure manner.
WBMD: 39.12 (+0.42), DGX: 71.68 (+0.03), MDRX: 11.80 (+0.04)
